A Proposal for Botulinum Toxin Type A Injection Into the Temporal Region in Chronic Migraine Headache
Abstract
:1. Introduction
2. Results
3. Discussion
4. Conclusions
5. Materials and Methods
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Natoli, J.; Manack, A.; Dean, B.; Butler, Q.; Turkel, C.; Stovner, L.; Lipton, R. Global prevalence of chronic migraine: A systematic review. Cephalalgia 2009, 30, 599–609. [Google Scholar] [CrossRef] [PubMed]
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013, 33, 629–808. [CrossRef] [PubMed] [Green Version]
- Tsui, J.; Eisen, A.; Mak, E.; Carruthers, J.; Scott, A.; Calne, D. A Pilot Study on the Use of Botulinum Toxin in Spasmodic Torticollis. Can. J. Neurol. Sci./J. Can. des Sci. Neurol. 1985, 12, 314–316. [Google Scholar] [CrossRef] [Green Version]
- Acquadro, M.A.; Borodic, G.E. Treatment of Myofascial Pain with Botulinum A Toxin. Anesthesiol. 1994, 80, 705. [Google Scholar] [CrossRef]
- Cheshire, W.P.; Abashian, S.W.; Mann, D.J.; Mann, J. Botulinum toxin in the treatment of myofascial pain syndrome. Pain 1994, 59, 65–69. [Google Scholar] [CrossRef]
- Foster, L.; Clapp, L.; Erickson, M.; Jabbari, B. Botulinum toxin A and chronic low back pain: A randomized, double-blind study. Neurol. 2001, 56, 1290–1293. [Google Scholar] [CrossRef]
- Freund, B.; Schwartz, M.; Symington, J. Botulinum toxin: New treatment for temporomandibular disorders. Br. J. Oral Maxillofac. Surg. 2000, 38, 466–471. [Google Scholar] [CrossRef] [Green Version]
- Johnstone, S.J.; Adler, C.H. Headache and facial pain responsive to botulinum toxin: An unusual presentation of blepharospasm. Headache: J. Head Face Pain 1998, 38, 366–368. [Google Scholar] [CrossRef] [Green Version]
- Polo, K.B.; Jabbari, B. Effectiveness of botulinum toxin type A against painful limb myoclonus of spinal cord origin. Mov. Disord. 2004, 9, 233–235. [Google Scholar] [CrossRef]
- Singh, J.A. Use of botulinum toxin in musculoskeletal pain. F1000Research 2013, 2, 52. [Google Scholar] [CrossRef]
- Zermann, D.-H.; Ishigooka, M.; Schubert, J.; A Schmidt, R. Perisphincteric injection of botulinum toxin type A. A treatment option for patients with chronic prostatic pain? Eur. Urol. 2000, 38, 393–399. [Google Scholar] [CrossRef] [PubMed]
- Wheeler, A.; Smith, H.S. Botulinum toxins: Mechanisms of action, antinociception and clinical applications. Toxicol. 2013, 306, 124–146. [Google Scholar] [CrossRef] [PubMed]
- Filippi, G.M.; Errico, P.; Santarelli, R.; Bagolini, B.; Manni, E. Botulinum a Toxin Effects on Rat Jaw Muscle Spindles. Acta Oto-Laryngologica 1993, 113, 400–404. [Google Scholar] [CrossRef] [PubMed]
- Rosales, R.L.; Arimura, K.; Takenaga, S.; Osame, M. Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection. Muscle Nerve 1996, 19, 488–496. [Google Scholar] [CrossRef]
- Ishikawa, H.; Mitsui, Y.; Yoshitomi, T.; Mashimo, K.; Aoki, S.; Mukuno, K.; Shimizu, K. Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles. Jpn. J. Ophthalmol. 2000, 44, 106–109. [Google Scholar] [CrossRef]
- Durham, P.L.; Cady, R. Insights into the mechanism of onabotulinumtoxinA in chronic migraine. Headache: J. Head Face Pain 2011, 51, 1573–1577. [Google Scholar] [CrossRef]
- Blumenfeld, A.; Silberstein, S.D.; Dodick, D.W.; Aurora, S.K.; Turkel, C.C.; Binder, W.J. Method of Injection of OnabotulinumtoxinA for Chronic Migraine: A Safe, Well-Tolerated, and Effective Treatment Paradigm Based on the PREEMPT Clinical Program. Headache J. Head Face Pain 2010, 50, 1406–1418. [Google Scholar] [CrossRef]
- Levin, M. Nerve blocks in the treatment of headache. Neurother. 2010, 7, 197–203. [Google Scholar] [CrossRef]
- Baumel, J.J.; Vanderheiden, J.P.; McElenney, J.E. The auriculotemporal nerve of man. Am. J. Anat. 1971, 130, 431–440. [Google Scholar] [CrossRef]
- Jiang, H.-Y.; Chen, S.; Zhou, J.; Leung, K.K.; Yu, P. Diffusion of Two Botulinum Toxins Type A on the Forehead: Double-Blinded, Randomized, Controlled Study. Dermatol. Surg. 2014, 40, 184–192. [Google Scholar] [CrossRef]
- Kerscher, M.; Roll, S.; Becker, A.; Wigger-Alberti, W. Comparison of the spread of three botulinum toxin type A preparations. Arch. Dermatol. Res. 2011, 304, 155–161. [Google Scholar] [CrossRef] [PubMed]
- Ramirez-Castaneda, J.; Jankovic, J.; Comella, C.; Dashtipour, K.; Fernandez, H.H.; Mari, Z. Diffusion, spread, and migration of botulinum toxin. Mov. Disord. 2013, 28, 1775–1783. [Google Scholar] [CrossRef]
- Ashkenazi, A.; Blumenfeld, A. OnabotulinumtoxinA for the Treatment of Headache. Headache: J. Head Face Pain 2013, 53, 54–61. [Google Scholar] [CrossRef] [PubMed]
- Aoki, K. Review of a Proposed Mechanism for the Antinociceptive Action of Botulinum Toxin Type A. NeuroToxicology 2005, 26, 785–793. [Google Scholar] [CrossRef] [PubMed]
- Aoki, K.R. Evidence for antinociceptive activity of botulinum toxin type A in pain management. Headache: J. Head Face Pain 2003, 43, 9–15. [Google Scholar] [CrossRef] [PubMed]
- Dolly, O. Synaptic transmission: Inhibition of neurotransmitter release by botulinum toxins. Headache: J. Head Face Pain 2003, 43, 16–24. [Google Scholar] [CrossRef]
- Durham, P.L.; Cady, R.; Cady, R. Regulation of Calcitonin Gene-Related Peptide Secretion From Trigeminal Nerve Cells by Botulinum Toxin Type A: Implications for Migraine Therapy. Headache J. Head Face Pain 2004, 44, 35–43. [Google Scholar] [CrossRef]
- Filipović, B.; Matak, I.; Bach-Rojecky, L.; Lacković, Z. Central Action of Peripherally Applied Botulinum Toxin Type A on Pain and Dural Protein Extravasation in Rat Model of Trigeminal Neuropathy. PLoS ONE 2012, 7, e29803. [Google Scholar] [CrossRef] [Green Version]
- Matak, I.; Bach-Rojecky, L.; Filipovic, B.; Lacković, Z. Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A. Neuroscience 2011, 186, 201–207. [Google Scholar] [CrossRef] [Green Version]
- Matak, I.; Lacković, Z. Botulinum toxin A, brain and pain. Prog. Neurobiol. 2014, 119, 39–59. [Google Scholar] [CrossRef] [Green Version]
- Pellett, S.; Yaksh, T.L.; Ramachandran, R. Current Status and Future Directions of Botulinum Neurotoxins for Targeting Pain Processing. Toxins 2015, 7, 4519–4563. [Google Scholar] [CrossRef] [PubMed]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kim, Y.-g.; Bae, J.-H.; Kim, H.; Wang, S.-J.; Kim, S.T. A Proposal for Botulinum Toxin Type A Injection Into the Temporal Region in Chronic Migraine Headache. Toxins 2020, 12, 214. https://doi.org/10.3390/toxins12040214
Kim Y-g, Bae J-H, Kim H, Wang S-J, Kim ST. A Proposal for Botulinum Toxin Type A Injection Into the Temporal Region in Chronic Migraine Headache. Toxins. 2020; 12(4):214. https://doi.org/10.3390/toxins12040214
Chicago/Turabian StyleKim, Young-gun, Jung-Hee Bae, Hyeyun Kim, Shuu-Jiun Wang, and Seong Taek Kim. 2020. "A Proposal for Botulinum Toxin Type A Injection Into the Temporal Region in Chronic Migraine Headache" Toxins 12, no. 4: 214. https://doi.org/10.3390/toxins12040214
APA StyleKim, Y. -g., Bae, J. -H., Kim, H., Wang, S. -J., & Kim, S. T. (2020). A Proposal for Botulinum Toxin Type A Injection Into the Temporal Region in Chronic Migraine Headache. Toxins, 12(4), 214. https://doi.org/10.3390/toxins12040214